Sigma Xi Publications



American Scientist

mRNA in a Pill

Vaccines based on messenger RNA (mRNA) are nearly always administered by injection. But what if mRNA therapeutics could instead be packed into pills? In “Messenger RNA Can Do More for Medicine” (pages 32–39), Wei Tao and Xiangang Huang argue that an mRNA pill would eliminate many barriers to more widespread adoption of mRNA vaccines. The pill form would also open new opportunities for care, such as mRNA therapeutics that could coax a patient’s own cells to produce proteins to counter chronic health conditions. But first, researchers must learn how to usher fragile strands of mRNA through the gastrointestinal system’s powerful defenses and into intestinal cells. The authors designed a method that protects mRNA (pink) within fatty bubbles known as lipid nanoparticles (purple). They then pack these lipid nanoparticles into pills that shed layers of protection at the precise moments necessary for mRNA to reach its target. (Illustration by Joana Carvalho.)

January–February 2026

Sigma Xi Publications